豐立智能(301368.SZ):對人形機器人產業一直保持密切關注,並且開發相對應的產品並已實現了小批量出貨給客户
格隆匯11月22日丨豐立智能(301368.SZ)於近期投資者關係活動表示,公司對人形機器人產業一直保持密切關注,並且開發相對應的產品並已實現了小批量出貨給客户。包括傘齒和圓柱齒,以及粉末齒,可以用於機器人的身體關節和靈巧手模組;諧波和行星減速器,可用於人形機器人的旋轉執行器;以及用於靈巧手的小傘輪和微型減速箱。此外,基於一直以來的技術積累,公司和行業一些頭部企業也在聯合研發。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.